Lespagnol A, Duflaut D, Beekman C, Blanc L, Fiucci G, Marine J-C, Vidal M, Amson R, Telerman A
Laboratoire de Biotechnologie et Pharmacologie génétique Appliquée (LBPA), Ecole Normale Supérieure, Cachan, France.
Cell Death Differ. 2008 Nov;15(11):1723-33. doi: 10.1038/cdd.2008.104. Epub 2008 Jul 11.
TSAP6 (tumor suppressor-activated pathway 6), also known as Steap3, is a direct p53 transcriptional target gene. It regulates protein secretion, for example translationally controlled tumor protein (TCTP), which is implicated in tumor reversion. In keeping with the latter, we show herein that TSAP6 is a glycosylated protein present in the trans-Golgi network, endosomal-vesicular compartment and cytoplasmic membrane. To further investigate the physiological function of TSAP6, we have generated TSAP6-deficient mice. These mice exhibit microcytic anemia with abnormal reticulocyte maturation and deficient transferrin receptor downregulation, a process known to be dependent on exosomal secretion. Moreover, we provide direct evidence that exosome production is severely compromised in TSAP6-null cells. Finally, we show that the DNA damage-induced p53-dependent nonclassical exosomal secretory pathway is abrogated in TSAP6-null cells. Given the fact that exosomes are used as cell-free vaccines against cancer and that they could be involved in the biogenesis and spread of human immunodeficiency virus, it is important to understand their regulation. The results presented here provide the first genetic demonstration that exosome formation is a tightly controlled biological process dependent of TSAP6.
TSAP6(肿瘤抑制激活通路6),也被称为Steap3,是一个直接受p53转录调控的靶基因。它调控蛋白质分泌,例如翻译控制肿瘤蛋白(TCTP),该蛋白与肿瘤逆转有关。与此相符的是,我们在此表明TSAP6是一种存在于反式高尔基体网络、内体-囊泡区室和细胞质膜中的糖基化蛋白。为了进一步研究TSAP6的生理功能,我们培育出了TSAP6基因敲除小鼠。这些小鼠表现出小细胞性贫血,伴有网织红细胞成熟异常和转铁蛋白受体下调缺陷,这一过程已知依赖于外泌体分泌。此外,我们提供了直接证据表明TSAP6基因缺失的细胞中外泌体生成严重受损。最后,我们表明在TSAP6基因缺失的细胞中,DNA损伤诱导的p53依赖性非经典外泌体分泌途径被废除。鉴于外泌体被用作抗癌的无细胞疫苗,并且它们可能参与人类免疫缺陷病毒的生物发生和传播,了解它们的调控机制很重要。此处呈现的结果首次通过遗传学证明外泌体形成是一个依赖于TSAP6的严格受控的生物学过程。